Diagnoplex Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • M&A

Diagnoplex General Information

Description

Developer of non invasive colorectal cancer screening tests. The company develops clinical laboratory kits for screening colorectal cancer, as well as for the detection of colon cancer. It also discovers and optimizes biomarker combinations to detect cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Chemin de la Vulliette 4
  • CH-1000 Lausanne
  • Switzerland
+41 021
Primary Industry
Laboratory Services (Healthcare)
Acquirer
Vertical(s)
Corporate Office
  • Chemin de la Vulliette 4
  • CH-1000 Lausanne
  • Switzerland
+41 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Diagnoplex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 12-Feb-2015 Completed Generating Revenue
2. Early Stage VC 07-Jun-2013 Completed Startup
1. Early Stage VC (Series A) 10-Dec-2008 $8.33M $8.33M Completed Startup
To view Diagnoplex’s complete valuation and funding history, request access »

Diagnoplex Patents

Diagnoplex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20150299802-A1 Biomarker combinations for colorectal tumors Active 05-Nov-2012
WO-2014068124-A1 Biomarker combinations for colorectal tumors Inactive 05-Nov-2012
AU-2008300338-A1 Biomarker combinations for colorectal cancer Inactive 04-Jun-2007
CA-2688558-A1 Biomarker combinations for colorectal cancer Inactive 04-Jun-2007
EP-2171470-A2 Biomarker combinations for colorectal cancer Inactive 04-Jun-2007 G01N33/57535
To view Diagnoplex’s complete patent history, request access »

Diagnoplex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Diagnoplex Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
DEFI Gestion PE/Buyout Minority
Debiopharm Innovation Fund Corporate Venture Capital Minority
NeoMed Management Venture Capital Minority
Novartis Venture Fund Corporate Venture Capital Minority
To view Diagnoplex’s complete investors history, request access »

Diagnoplex FAQs

  • When was Diagnoplex founded?

    Diagnoplex was founded in 2004.

  • Where is Diagnoplex headquartered?

    Diagnoplex is headquartered in Lausanne, Switzerland.

  • What is the size of Diagnoplex?

    Diagnoplex has 7 total employees.

  • What industry is Diagnoplex in?

    Diagnoplex’s primary industry is Laboratory Services (Healthcare).

  • Is Diagnoplex a private or public company?

    Diagnoplex is a Private company.

  • What is Diagnoplex’s current revenue?

    The current revenue for Diagnoplex is .

  • How much funding has Diagnoplex raised over time?

    Diagnoplex has raised $9.7M.

  • Who are Diagnoplex’s investors?

    DEFI Gestion, Debiopharm Innovation Fund, NeoMed Management, and Novartis Venture Fund have invested in Diagnoplex.

  • When was Diagnoplex acquired?

    Diagnoplex was acquired on 12-Feb-2015.

  • Who acquired Diagnoplex?

    Diagnoplex was acquired by Novigenix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process